Company Statement: SeraCare announces definitive agreement to be acquired by Linden Capital Partners
MLex Summary: Chicago-based private equity firm, Linden Capital Partners, has signed an agreement to acquire biotech company, SeraCare Life Sciences, for $82 million. The transaction is subject to regulatory approvals, and it is expected to close in...To view the full article, register now.
Already a subscriber? Click here to view full article